EUVIMEDEUVIMED entdecken
Open Access

Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management

Aftab Ahmad, Anwar A Alghamdi

Bioinformation · 31.05.2023 · 19 (5) · 633-637

DOI: 10.6026/97320630019633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.05.2023. Verfasst von Aftab Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Health Information Technology Department, The Applied College, King Abdulaziz University, Jeddah, Saudi Arabia. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is a major metabolic disorder in developed countries, with an increasing number of people affected globally. PPARγ is primarily expressed in adipose tissue with a lesser extent in other tissues. PPARγ is an important mediator in several metabolic processes such as insulin sensitivity and adipogenesis. Because of its critical role in these processes, PPARγ is regarded as a critical target for therapeutic intervention in obesity treatment. A library of 2,320 bioactive compounds was screened insilico to identify compounds that strongly interact with the PPARγ protein. The compounds Z1982689600, Z2235802137, Z2235801970, and Z2037275165, demonstrated notable binding affinity values towards the PPARγ protein with values of -12.1, -11.7, -11.4, and -11.4 kcal/mol, respectively, which were higher than the binding affinity value observed for the control compound (-10.5 kcal/mol). These compounds bind tightly to PPARγ and have several amino acid residue interactions in common with the control compound. In addition, these compounds meet the ADMET criteria. These compounds could aid in the development of PPARγ antagonists for the management of obesity associated diabetes. However, additional research is needed to optimize their efficacy in wet laboratory conditions.

Schlagwörter

Stichwörter der Autor:innen

ADMETObesityPPARγbioactive compounds

Autor:innen und Institutionen

  • Health Information Technology Department, The Applied College, King Abdulaziz University, Jeddah, Saudi Arabia.

Zitieren

APA

Ahmad, A., & Alghamdi, A. A. (2023). Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management. Bioinformation, 19(5), 633-637. https://doi.org/10.6026/97320630019633

Vancouver

Ahmad A, Alghamdi AA. Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management. Bioinformation. 2023;19(5):633-637. doi:10.6026/97320630019633

BibTeX
@article{Ahmad2023,
  author = {Ahmad, Aftab and Alghamdi, Anwar A},
  title = {Molecular docking analysis of PPARγ antagonists for obesity associated diabetes management},
  journal = {Bioinformation},
  year = {2023},
  volume = {19},
  number = {5},
  pages = {633--637},
  doi = {10.6026/97320630019633}
}
Kostenlos starten →